USE OF TOPICAL CIDOFOVIR FOR THE TREATMENT OF RESISTANT HERPES SIMPLEX VIRAL INFECTIONS IN POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: TWO CASE REPORTS

被引：0
|
作者：
Trevino, C. M. [1 ]
Westmoreland, M. D. [1 ]
Hosing, C. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.629
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
588
引用
收藏
页码：S363 / S364
页数：2
相关论文
共 50 条
  • [31] Successful treatment with refractory myasthenia gravis that developed after allogeneic hematopoietic stem cell transplantation: two case reports
    Zhang, Huili
    Wen, Yi
    Ou, Yaotong
    Chen, Xi
    Peng, Yu
    Lai, Mingjun
    Mo, Wenjian
    Wang, Honghao
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [32] Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients
    Bhatti, Zahida
    Shaukat, Aasma
    Almyroudis, Nikolaos G.
    Segal, Brahm H.
    MYCOPATHOLOGIA, 2006, 162 (01) : 1 - 15
  • [33] Review of Epidemiology, Diagnosis, and Treatment of Invasive Mould Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Zahida Bhatti
    Aasma Shaukat
    Nikolaos G. Almyroudis
    Brahm H. Segal
    Mycopathologia, 2006, 162 : 1 - 15
  • [34] Infection due to aciclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoetic stem cell transplantation
    Venard, V
    Dauendorffer, JN
    Carret, AS
    Corsaro, D
    Edert, D
    Bordigoni, P
    Le Faou, A
    PATHOLOGIE BIOLOGIE, 2001, 49 (07): : 553 - 558
  • [35] Risk Factors and Clinical Outcome for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
    Uhlin, Michael
    Stikvoort, Arwen
    Sundin, Mikael
    Mattsson, Jonas
    Remberger, Mats
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S170 - S170
  • [36] Prophylaxis for Herpes Simplex Virus Reactivation in Patients after Allogeneic Hematopoietic Stem Cell Transplantation; Effects and Clinical Outcome
    Uhlin, Michael
    Stikvoort, Arwen
    Sundin, Mikael
    Mattsson, Jonas
    Remberger, Mats
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S179 - S180
  • [37] Herpes simplex virus (HSV) infection in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Atilla, E.
    Ozel, F.
    Yilmaz, V.
    Atilla, P. Ataca
    Atesagaoglu, B.
    Bozdag, S. Civriz
    Yuksel, M. Kurt
    Toprak, S. K.
    Topcuoglu, P.
    Akan, H.
    Demirer, T.
    Arslan, O.
    Ozcan, M.
    Ilhan, O.
    Beksac, M.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S252 - S253
  • [38] Risk factors and clinical outcome for Herpes Simplex Virus reactivation in patients after allogeneic hematopoietic stem cell transplantation
    Uhlin, M.
    Stikvoort, A.
    Sundin, M.
    Mattsson, J.
    Remberger, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S407 - S408
  • [39] Response to treatment in community respiratory viral infections in adult allogeneic bone marrow and peripheral blood stem cell transplant patients
    Copland, M
    Carman, W
    Franklin, I
    Holyoake, T
    McQuaker, I
    Jones, B
    Parker, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S201 - S201
  • [40] AVAPRITINIB IN THE POST-ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT SETTING IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
    Christen, Deborah
    Luebke, Johannes
    Schwaab, Juliana
    Kaiser, Anne
    Rylova, Svetlana
    Dimitrijevic, Sasa
    Bidollari, Ilda
    Panse, Jens Peter
    Reiter, Andreas
    BONE MARROW TRANSPLANTATION, 2024, 59 : 530 - 531
12345